Mutation of HERC2 causes developmental delay with Angelman-like features.

Autor:	Harlalka GV; Centre for Human Genetics, St George's University of London, London, UK., Baple EL, Cross H, Kühnle S, Cubillos-Rojas M, Matentzoglu K, Patton MA, Wagner K, Coblentz R, Ford DL, Mackay DJ, Chioza BA, Scheffner M, Rosa JL, Crosby AH
Jazyk:	angličtina
Zdroj:	Journal of medical genetics [J Med Genet] 2013 Feb; Vol. 50 (2), pp. 65-73. Date of Electronic Publication: 2012 Dec 14.
DOI:	10.1136/jmedgenet-2012-101367
Abstrakt:	Background: Deregulation of the activity of the ubiquitin ligase E6AP (UBE3A) is well recognised to contribute to the development of Angelman syndrome (AS). The ubiquitin ligase HERC2, encoded by the HERC2 gene is thought to be a key regulator of E6AP. Methods and Results: Using a combination of autozygosity mapping and linkage analysis, we studied an autosomal-recessive neurodevelopmental disorder with some phenotypic similarities to AS, found among the Old Order Amish. Our molecular investigation identified a mutation in HERC2 associated with the disease phenotype. We establish that the encoded mutant HERC2 protein has a reduced half-life compared with its wild-type counterpart, which is associated with a significant reduction in HERC2 levels in affected individuals. Conclusions: Our data implicate a model in which disruption of HERC2 function relates to a reduction in E6AP activity resulting in neurodevelopmental delay, suggesting a previously unrecognised role of HERC2 in the pathogenesis of AS.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu